104 related articles for article (PubMed ID: 38831614)
1. Initial micafungin treatment does not improve outcomes compared to fluconazole treatment in immunocompromised and critically ill patients with candidaemia.
Theodore DA; Henneman AD; Loo A; Shields RK; Eschenauer G; Sobieszczyk ME; Kubin CJ
J Antimicrob Chemother; 2024 Jun; ():. PubMed ID: 38831614
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).
Chiotos K; Vendetti N; Zaoutis TE; Baddley J; Ostrosky-Zeichner L; Pappas P; Fisher BT
J Antimicrob Chemother; 2016 Dec; 71(12):3536-3539. PubMed ID: 27494929
[TBL] [Abstract][Full Text] [Related]
4. Determinants of mortality in non-neutropenic ICU patients with candidaemia.
Marriott DJ; Playford EG; Chen S; Slavin M; Nguyen Q; Ellis D; Sorrell TC;
Crit Care; 2009; 13(4):R115. PubMed ID: 19594912
[TBL] [Abstract][Full Text] [Related]
5. Resource utilization and cost of treatment with anidulafungin or fluconazole for candidaemia and other forms of invasive candidiasis: focus on critically ill patients.
Reboli AC; Rotstein C; Kett DH; Maschio M; Cartier S; Chambers R; Tarallo M
Pharmacoeconomics; 2011 Aug; 29(8):705-17. PubMed ID: 21591820
[TBL] [Abstract][Full Text] [Related]
6. Antifungal resistance in patients with Candidaemia: a retrospective cohort study.
Aldardeer NF; Albar H; Al-Attas M; Eldali A; Qutub M; Hassanien A; Alraddadi B
BMC Infect Dis; 2020 Jan; 20(1):55. PubMed ID: 31952505
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough candidaemia in the era of broad-spectrum antifungal therapies.
Cuervo G; Garcia-Vidal C; Nucci M; Puchades F; Fernández-Ruiz M; Obed M; Manzur A; Gudiol C; Pemán J; Aguado JM; Ayats J; Carratalà J
Clin Microbiol Infect; 2016 Feb; 22(2):181-188. PubMed ID: 26460064
[TBL] [Abstract][Full Text] [Related]
8. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
[TBL] [Abstract][Full Text] [Related]
9. Effect of initial antifungal therapy on mortality among patients with bloodstream infections with different Candida species and resistance to antifungal agents: A multicentre observational study by the Turkish Fungal Infections Study Group.
Doğan Ö; Yeşilkaya A; Menekşe Ş; Güler Ö; Karakoç Ç; Çınar G; Kapmaz M; Aydın M; Keske Ş; Şahin S; Hacıseyitoğlu D; Yalçın D; Tekin S; Ataç N; Albayrak Ö; Aksu ED; Can F; Ergönül Ö
Int J Antimicrob Agents; 2020 Jul; 56(1):105992. PubMed ID: 32335275
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.
Shah DN; Yau R; Weston J; Lasco TM; Salazar M; Palmer HR; Garey KW
J Antimicrob Chemother; 2011 Sep; 66(9):2146-51. PubMed ID: 21700622
[TBL] [Abstract][Full Text] [Related]
11. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
[TBL] [Abstract][Full Text] [Related]
12. Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Slavin MA; Sorrell TC; Marriott D; Thursky KA; Nguyen Q; Ellis DH; Morrissey CO; Chen SC;
J Antimicrob Chemother; 2010 May; 65(5):1042-51. PubMed ID: 20202987
[TBL] [Abstract][Full Text] [Related]
13. Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.
van der Geest PJ; Rijnders BJ; Vonk AG; Groeneveld AB
Mycoses; 2016 Mar; 59(3):179-85. PubMed ID: 26707572
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for candidaemia and their cumulative effect over time in a cohort of critically ill, non-neutropenic patients.
Aljeboori Z; Gorelik A; Jenkins E; McFarlane T; Darvall J
Crit Care Resusc; 2018 Dec; 20(4):313-319. PubMed ID: 30482139
[TBL] [Abstract][Full Text] [Related]
15. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei.
Shorr AF; Wu C; Kothari S
J Antimicrob Chemother; 2011 Feb; 66(2):375-80. PubMed ID: 21147825
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for isolation of fluconazole and echinocandin non-susceptible
Papadimitriou-Olivgeris M; Spiliopoulou A; Fligou F; Tsiata E; Kolonitsiou F; Nikolopoulou A; Papamichail C; Spiliopoulou I; Marangos M; Christofidou M
J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34431765
[No Abstract] [Full Text] [Related]
17. Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study.
Eschenauer GA; Carver PL; Lin SW; Klinker KP; Chen YC; Potoski BA; Shields RK; Clancy CJ; Nguyen MH; Lam SW
J Antimicrob Chemother; 2013 Apr; 68(4):922-6. PubMed ID: 23212115
[TBL] [Abstract][Full Text] [Related]
18. Initial Antifungal Strategy Reduces Mortality in Critically Ill Patients With Candidemia: A Propensity Score-Adjusted Analysis of a Multicenter Study.
Garnacho-Montero J; Díaz-Martín A; Cantón-Bulnes L; Ramírez P; Sierra R; Arias-Verdú D; Rodríguez-Delgado M; Loza-Vázquez A; Rodriguez-Gomez J; Gordón M; Estella Á; García-Garmendia JL
Crit Care Med; 2018 Mar; 46(3):384-393. PubMed ID: 29189345
[TBL] [Abstract][Full Text] [Related]
19. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
20. Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance.
Fernández-Ruiz M; Guinea J; Lora-Pablos D; Zaragoza Ó; Puig-Asensio M; Almirante B; Cuenca-Estrella M; Aguado JM; ;
Clin Microbiol Infect; 2017 Sep; 23(9):672.e1-672.e11. PubMed ID: 28143788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
